Literature DB >> 28460045

Large Reduction in Adiponectin During Pregnancy Is Associated With Large-for-Gestational-Age Newborns.

Tove Lekva1, Marie Cecilie Paasche Roland2,3, Annika E Michelsen1,4, Camilla Margrethe Friis2, Pål Aukrust1,4,5,6,7, Jens Bollerslev4,8, Tore Henriksen2,4, Thor Ueland1,4,7.   

Abstract

Context: Fetuses exposed to an obese intrauterine environment are more likely to be born large-for-gestational age (LGA) and are at increased risk of obesity in childhood and cardiovascular disease and/or type 2 diabetes mellitus as adults, but which factors that influence the intrauterine environment is less clear. Objective: To investigate the association between circulating levels of leptin and adiponectin, measured multiple times during pregnancy, and birth weight and prevalence of LGA or small-for-gestational-age infants. The association between birth weight and messenger RNA (mRNA) expression of adiponectin receptors and genes involved in nutrient transport in the placenta was also investigated. Design: Population-based prospective cohort [substudy of the STORK study (STORe barn og Komplikasjoner, translated as Large Babies and Complications)] from 2001 to 2008. Setting: University hospital. Patients or other participants: 300 women. Main Outcome Measures: Oral glucose tolerance test was performed twice along with adiponectin and leptin levels measured four times during pregnancy.
Results: Circulating adiponectin was lower in mothers who gave birth to LGA offspring or had fetuses with high intrauterine abdominal circumference late in pregnancy. Adiponectin decreased most from early to late pregnancy in mothers who gave birth to LGA offspring, and the decrease was an independent predictor of birth weight. Adiponectin receptor 2 and system A amino acid transporter mRNA expression in placentas was negatively correlated with birth weight and was lower in placentas from LGA infants. Conclusions: Our findings suggest that maternal adiponectin may be an important predictor of fetal growth and birth weight, independent of body mass index and insulin resistance.
Copyright © 2017 by the Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28460045     DOI: 10.1210/jc.2017-00289

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Longitudinal changes in adipokines and free leptin index during and after pregnancy in women with obesity.

Authors:  Ulrika Andersson-Hall; Pernilla Svedin; Henrik Svensson; Malin Lönn; Carina Mallard; Agneta Holmäng
Journal:  Int J Obes (Lond)       Date:  2019-09-24       Impact factor: 5.095

2.  Dietary total antioxidant capacity during pregnancy and birth outcomes.

Authors:  Daniela Saes Sartorelli; Mariana Rinaldi Carvalho; Izabela da Silva Santos; Lívia Castro Crivellenti; João Paulo Souza; Laércio Joel Franco
Journal:  Eur J Nutr       Date:  2020-04-29       Impact factor: 5.614

3.  Gestational Weight Gain Influences the Adipokine-Oxidative Stress Association during Pregnancy.

Authors:  Juan Mario Solis Paredes; Otilia Perichart Perera; Araceli Montoya Estrada; Enrique Reyes Muñoz; Salvador Espino Y Sosa; Veronica Ortega Castillo; Diana Medina Bastidas; Maricruz Tolentino Dolores; Maribel Sanchez Martinez; Sonia Nava Salazar; Guadalupe Estrada Gutierrez
Journal:  Obes Facts       Date:  2021-09-14       Impact factor: 3.942

4.  Insulin Increases Adipose Adiponectin in Pregnancy by Inhibiting Ubiquitination and Degradation: Impact of Obesity.

Authors:  Irving L M H Aye; Fredrick J Rosario; Anita Kramer; Oddrun Kristiansen; Trond M Michelsen; Theresa L Powell; Thomas Jansson
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

5.  Normalization of maternal adiponectin in obese pregnant mice prevents programming of impaired glucose metabolism in adult offspring.

Authors:  Jerad Dumolt; Theresa L Powell; Thomas Jansson; Fredrick J Rosario
Journal:  FASEB J       Date:  2022-07       Impact factor: 5.834

6.  Proinflammatory Diets during Pregnancy and Neonatal Adiposity in the Healthy Start Study.

Authors:  Brianna F Moore; Katherine A Sauder; Anne P Starling; James R Hébert; Nitin Shivappa; Brandy M Ringham; Deborah H Glueck; Dana Dabelea
Journal:  J Pediatr       Date:  2017-12-06       Impact factor: 4.406

7.  Continuous Glucose Monitoring, Glycemic Variability, and Excessive Fetal Growth in Pregnancies Complicated by Type 1 Diabetes.

Authors:  Bethany M Mulla; Nudrat Noor; Tamarra James-Todd; Elvira Isganaitis; Tamara C Takoudes; Ashley Curran; Celestine E Warren; Karen E O'Brien; Florence M Brown
Journal:  Diabetes Technol Ther       Date:  2018-06-14       Impact factor: 6.118

Review 8.  Maternal Non-glycemic Contributors to Fetal Growth in Obesity and Gestational Diabetes: Spotlight on Lipids.

Authors:  Linda A Barbour; Teri L Hernandez
Journal:  Curr Diab Rep       Date:  2018-05-09       Impact factor: 4.810

9.  Low CETP activity and unique composition of large VLDL and small HDL in women giving birth to small-for-gestational age infants.

Authors:  Marie Cecilie Paasche Roland; Kristin Godang; Pål Aukrust; Tore Henriksen; Tove Lekva
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

10.  Adiponectin links maternal metabolism to uterine contractility.

Authors:  Vibhuti Vyas; Damian D Guerra; Rachael Bok; Theresa Powell; Thomas Jansson; K Joseph Hurt
Journal:  FASEB J       Date:  2019-10-30       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.